Reviews in Cardiovascular Medicine (Jan 2022)

MicroRNAs in type 2 diabetes mellitus: potential role of physical exercise

  • Alex Cleber Improta-Caria,
  • Ricardo Augusto Leoni De Sousa,
  • Leonardo Roever,
  • Tiago Fernandes,
  • Edilamar Menezes de Oliveira,
  • Roque Aras Júnior,
  • Bruno Solano de Freitas Souza

DOI
https://doi.org/10.31083/j.rcm2301029
Journal volume & issue
Vol. 23, no. 1
p. 029

Abstract

Read online

Type 2 diabetes mellitus (T2DM) is a multifactorial metabolic disease, and its prevalence has grown worldwide. Several pathophysiological processes contribute to the development, progression and aggravating of the disease, for example, decreased insulin synthesis and secretion, insulin resistance, inflammation, and apoptosis, all these processes are regulated by various epigenetic factors, including microRNAs (miRNAs). MiRNAs are small non-coding RNAs, which are around 20 nucleotides in length and are regulators of gene expression at the post-transcriptional level, have a specific function of inhibiting or degrading a messenger RNA target. Thus, miRNAs modulate the expression of many associated genes with the pathophysiological processes in T2DM. On the other hand, miRNAs are also modulated through physical exercise (PE), which induces a change in their expression pattern during and after exercise. Some scientific evidence shows that PE modulates miRNAs beneficially and improves the signaling pathway of insulin resistance, however, little is known about the function of PE modulating miRNAs associated with the processes of insulin secretion, inflammation, and apoptosis. Thus, the objective of this review is to identify the miRNAs expression pattern in T2DM and compare it with the exercise-induced miRNAs expression pattern, identifying the signaling pathways that these miRNAs are regulating in the processes of insulin secretion, insulin resistance, inflammation, and apoptosis in T2DM, and how PE may have a potential role in modulating these signal transduction pathways, promoting benefits for patients with T2DM.

Keywords